Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Risk of hemorrhage associated with co-prescriptions for Ginkgo biloba and antiplatelet or anticoagulant drugs.

Chan AL, Leung HW, Wu JW, Chien TW.

J Altern Complement Med. 2011 Jun;17(6):513-7. doi: 10.1089/acm.2010.0295.

PMID:
21649517
2.

Patterns of combined prescriptions of aspirin-Ginkgo biloba in Taiwan: a population-based study.

Chang LC, Huang N, Chou YJ, Kao FY, Hsieh PC, Huang YT.

J Clin Pharm Ther. 2008 Jun;33(3):243-9. doi: 10.1111/j.1365-2710.2008.00911.x.

PMID:
18452411
3.

Haemorrhage due to Ginkgo biloba?

[No authors listed]

Prescrire Int. 2008 Feb;17(93):19.

PMID:
18383637
4.

Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence?

Bone KM.

Mol Nutr Food Res. 2008 Jul;52(7):764-71. doi: 10.1002/mnfr.200700098. Review.

PMID:
18214851
5.

Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers.

Kim BH, Kim KP, Lim KS, Kim JR, Yoon SH, Cho JY, Lee YO, Lee KH, Jang IJ, Shin SG, Yu KS.

Clin Ther. 2010 Feb;32(2):380-90. doi: 10.1016/j.clinthera.2010.01.027.

PMID:
20206795
6.

A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.

Tsai HH, Lin HW, Lu YH, Chen YL, Mahady GB.

PLoS One. 2013 May 9;8(5):e64255. doi: 10.1371/journal.pone.0064255. Print 2013. Review.

7.

Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients.

Abraham NS, Hartman C, Richardson P, Castillo D, Street RL Jr, Naik AD.

Circulation. 2013 Oct 22;128(17):1869-77. doi: 10.1161/CIRCULATIONAHA.113.004747. Epub 2013 Sep 11.

8.
9.

Potential drug-herb interaction with antiplatelet/anticoagulant drugs.

Saw JT, Bahari MB, Ang HH, Lim YH.

Complement Ther Clin Pract. 2006 Nov;12(4):236-41. Epub 2006 Jul 25.

PMID:
17030294
10.

Outcomes associated with combined antiplatelet and anticoagulant therapy.

Johnson SG, Rogers K, Delate T, Witt DM.

Chest. 2008 Apr;133(4):948-54. doi: 10.1378/chest.07-2627. Epub 2008 Jan 15.

PMID:
18198244
11.
12.

Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study.

Donzé J, Rodondi N, Waeber G, Cornuz J, Aujesky D.

Thromb Res. 2013 Jun;131(6):502-7. doi: 10.1016/j.thromres.2013.04.033. Epub 2013 May 30.

PMID:
23726965
13.

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.

Warfarin Antiplatelet Vascular Evaluation Trial Investigators, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G.

N Engl J Med. 2007 Jul 19;357(3):217-27.

14.

The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects.

Kim HS, Kim GY, Yeo CW, Oh M, Ghim JL, Shon JH, Kim EY, Kim DH, Shin JG.

Br J Clin Pharmacol. 2014 May;77(5):821-30. doi: 10.1111/bcp.12236.

15.

Effects of anticoagulant and antiplatelet drugs on the risk for hospital admission for traumatic injuries: a case-control and population-based study.

Di Bartolomeo S, Marino M, Valent F, De Palma R.

J Trauma Acute Care Surg. 2014 Feb;76(2):437-42. doi: 10.1097/TA.0b013e3182aa80f9.

PMID:
24398774
16.

[Effects of Ginkgo biloba extract on anticoagulation and blood drug level of warfarin in healthy wolunteers].

Zhou Y, Zeng R.

Zhongguo Zhong Yao Za Zhi. 2011 Aug;36(16):2290-3. Chinese.

PMID:
22097347
17.

Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.

Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E.

CMAJ. 2011 Nov 8;183(16):1835-43. doi: 10.1503/cmaj.100912. Epub 2011 Sep 26.

18.

Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis.

Kellermann AJ, Kloft C.

Pharmacotherapy. 2011 May;31(5):490-502. doi: 10.1592/phco.31.5.490. Review.

PMID:
21923430
19.

Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.

DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.

Pharmacotherapy. 2007 May;27(5):691-6.

PMID:
17461704
20.

The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation.

Howard PA, Ellerbeck EF, Engelman KK, Patterson KL.

Pharmacoepidemiol Drug Saf. 2002 Oct-Nov;11(7):569-76.

PMID:
12462133

Supplemental Content

Support Center